Risk Perception Intervention for High-Risk Diabetic Foot
Construction and Application of a Foot Ulcer Risk Perception Intervention Program for Diabetic Patients With High-risk Foot Based on Information Framework Effect
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
This study aims to evaluate the effect of health education based on information framing effects on foot ulcer risk perception in patients at high risk of diabetic foot. Study Design: A randomized controlled trial with three groups: Experimental Group 1 (Gain-Framed): Participants received a benefit framing message that emphasized the benefits of standardized foot care in reducing the likelihood and severity of foot ulcers, with an aim to reshape patients' perception of risk. Experimental Group 2 (Loss-Framed):Participants received a loss frame message that emphasized that neglecting foot care would increase the likelihood and severity of foot ulcers. The message was designed to awaken patients' awareness of crisis and risk perception. Control Group (Routine Messaging):Participants received the usual content of care in the endocrinology department without a specific framework. Participants: Diabetic foot patients at high risk from experimental group 1, experimental group 2, and control group 3. Inclusion criteria included adults with a diagnosis of diabetic foot at high risk. Intervention: The Total Study Period consisted of an intervention phase and a follow-up phase. The intervention phase started at the time of enrollment and lasted until the fourth week after discharge. The follow-up period lasted for 3 months. Data on local indicators were collected at baseline/before the intervention (T0), immediately after the intervention (T1), 1 month after the intervention (T2) and 3 months after the intervention (T3). Outcome Measures: Primary Outcomes: Foot ulcer risk perception: Assessed using The Tripartite Model of Risk Perception Scale. Secondary Outcomes: Foot care behavior score: Assessed using The Nottingham Foot Care Assessment Scale; Self-efficacy: Assessed using The Diabetes Self-Efficacy Scale; Intention to delay seeking medical help score:Assessed using the Questionnaire on Intention to Delay Seeking Medical Care for Patients with High-Risk Diabetic Foot; the incidence/recurrence rate of foot ulcers, and various laboratory indicators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started May 2026
Shorter than P25 for not_applicable diabetes-mellitus
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 12, 2026
May 1, 2026
8 months
April 28, 2026
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
foot ulcer risk perception score
Assessed using the Chinese version of the Tripartite Model of Risk Perception (TRIRISK) Scale, developed by Ferrer et al. in 2016. The scale consists of 18 items across 3 dimensions: rational perception, emotional perception, and experience perception. A Likert 7-point scoring method (1-7 points) is used. Higher scores indicate a higher individual perception of diabetic foot ulcer risk.
Baseline, at the end of intervention (week 4), and at 1 and 3 months post-intervention.
Secondary Outcomes (6)
Foot care behavior score
Baseline, at the end of intervention (week 4), and at 1 and 3 months post-intervention
Diabetes self-efficacy score
Baseline, at the end of intervention (week 4), and at 1 and 3 months post-intervention.
Baseline Demographic and Clinical Characteristics
Baseline (T0)
Medical Help-seeking Delay Intention score
Baseline (T0), at the end of intervention (T1), and at 1 month (T2) and 3 months (T3) post-intervention.
Glycemic Control Indicators
HbA1c will be measured at baseline (T0) and 3 months post-intervention (T3).
- +1 more secondary outcomes
Other Outcomes (2)
laboratory index
Baseline (T0) and 3 months post-intervention (T3).
DFU Incidence and Recurrence.
From baseline through the 3-month follow-up.
Study Arms (3)
Experimental Group 1: Gain-Framed
EXPERIMENTALParticipants will receive a gain-framed health education intervention starting during hospitalization and continuing for 4 weeks post-discharge via WeChat. They will be provided with a gain-framed "High-Risk Foot Protection Manual," educational videos, and peer success stories. For example, a message will state: "Mastering proper foot care helps establish an external protective barrier for your feet, effectively preventing 50% of foot ulcers and maintaining your independent mobility." Participants will also submit foot care photo check-ins via WeChat, receiving gain-framed positive reinforcement regarding their healthy habits.
Experimental Group 2: Loss-Framed
EXPERIMENTALParticipants will receive a loss-framed health education intervention following the same methods (face-to-face and WeChat) as Group 1. They will receive a loss-framed manual, videos, and peer warning stories. An example message will state: "Ignoring proper foot care routines can cause minor wounds to rapidly deteriorate into deep infections, leading to a 19% risk of amputation, loss of mobility, and heavy financial burdens." During their WeChat check-ins, they will receive loss-framed reminders emphasizing the severe risks of neglecting foot care.
Control Group: Routine Care
ACTIVE COMPARATORParticipants will receive standard, neutral health education regarding diabetic foot care without any specific information framing. They will receive standard, neutral endocrinology department routine care without any specific information framework.
Interventions
Participants will receive a gain-framed health education intervention starting during hospitalization and continuing for 4 weeks post-discharge via WeChat. They will be provided with a gain-framed "High-Risk Foot Protection Manual," educational videos, and peer success stories. For example, a message will state: "Mastering proper foot care helps establish an external protective barrier for your feet, effectively preventing 50% of foot ulcers and maintaining your independent mobility." Participants will also submit foot care photo check-ins via WeChat, receiving gain-framed positive reinforcement regarding their healthy habits.
Participants will receive a loss-framed health education intervention following the same methods (face-to-face and WeChat) as Group 1. They will receive a loss-framed manual, videos, and peer warning stories. An example message will state: "Ignoring proper foot care routines can cause minor wounds to rapidly deteriorate into deep infections, leading to a 19% risk of amputation, loss of mobility, and heavy financial burdens." During their WeChat check-ins, they will receive loss-framed reminders emphasizing the severe risks of neglecting foot care.
Participants will receive standard, objective health education regarding diabetic foot care without any specific information framing. This includes routine nursing care from the Department of Endocrinology, such as inpatient foot skin assessment, basic hygiene education, and standard hospital discharge guidance. Post-discharge follow-ups will be conducted via telephone or WeChat to monitor recovery and medication adherence according to the hospital's standard protocol.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old with good communication and cognitive abilities.
- Meet the World Health Organization (WHO) diagnostic criteria for Type 1 or Type 2 Diabetes Mellitus.
- Meet the diagnostic criteria for high-risk diabetic foot according to the International Working Group on the Diabetic Foot (IWGDF) 2023 standards.
- Proficient in the use of a smartphone and related applications (e.g., WeChat).
- Voluntarily participate in the study and provide signed informed consent.
You may not qualify if:
- Patients with impaired consciousness, severe organ dysfunction, or other physical disabilities that lead to being bedbound or unable to perform foot care.
- Patients with peripheral neuropathy caused by non-diabetic factors (e.g., toxic, nutritional, or hereditary neuropathies).
- Patients with gestational diabetes or those with pre-existing diabetes who are currently pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data analysts are also blinded to the group assignments during the data analysis process.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chief Nurse,Deputy Director of Nursing Department
Study Record Dates
First Submitted
April 28, 2026
First Posted
May 12, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 12, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
The dataset contains sensitive clinical information and there is currently no formal plan for public data sharing.